Keith R. Kaderlik

Polymorphisms for aromatic amine metabolism in humans: relevance for human carcinogenesis.

Fred F. Kadlubar, Marguerite A. Butler, Keith R. Kaderlik et al. · Environmental Health Perspectives · 1992 · 230 citations · Full text

Medicine, Molecular Genetics, Metabolism +9

Identification of N-(deoxyguanosin-8-yl)-2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine as the major adduct formed by the food-borne carcinogen, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine, with DNA

Dongxin Lin, Keith R. Kaderlik, Robert J. Turesky et al. · Chemical Research in Toxicology · 1992 · 161 citations

Pharmacy, Molecular Biology, Toxicology +17

Metabolic activation pathway for the formation of DNA adducts of the carcinogen 2-amino-l-methyl-6-phenyUmidazo[4,5-<i>b</i>]pyridine (PhIP) in rat extrahepatic tissues

Keith R. Kaderlik, Rodney F. Minchin, Gerard J. Mulder et al. · Carcinogenesis · 1994 · 146 citations

Pharmacy, Pharmacology, Toxicology +12

Analysis of DNA Adducts of 2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine in Rat and Human Tissues by Alkaline Hydrolysis and Gas Chromatography/Electron Capture Mass Spectrometry: Validation by Comparison with 32P-Postlabeling

Marlin D. Friesen, Keith R. Kaderlik, Dongxin Lin et al. · Chemical Research in Toxicology · 1994 · 140 citations

Pharmacy, Biochemistry, Toxicology +9

Chemoprotection against the formation of colon DNA adducts from the food-borne carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in the rat

Wolfgang W. Huber, L. Patrice McDaniel, Keith R. Kaderlik et al. · Mutation research. Fundamental and molecular mechanisms of mutagenesis · 1997 · 112 citations

Pharmacy, Toxicology, Cancer Prevention +9